These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14727847)

  • 21. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a modified-release pellets formulation--with metoprolol tartrat and kinetic aspects of in vitro release.
    Todoran N; Ciurba A; Al Hussein S; Lazar L; Ion V; Antonoaea P
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):1143-9. PubMed ID: 25581981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets.
    Polli JE; Rekhi GS; Augsburger LL; Shah VP
    J Pharm Sci; 1997 Jun; 86(6):690-700. PubMed ID: 9188051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability studies of expired tablets of metoprolol tartrate and propranolol hydrochloride. Part 1. Content determination.
    Jasińska M; Karwowski B; Orszulak-Michalak D; Kurczewska U
    Acta Pol Pharm; 2009; 66(6):697-701. PubMed ID: 20050534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bioavailability of two beta-blockers preadsorbed onto charcoal.
    Roivas L; Ojala-Karlsson P; Neuvonen PJ
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):125-32. PubMed ID: 7911863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, development and in-vitro evaluation of metoprolol tartrate tablets containing xanthan-tragacanth.
    Rasul A; Iqbal M; Murtaza G; Waqas MK; Hanif M; Khan SA; Bhatti NS
    Acta Pol Pharm; 2010; 67(5):517-22. PubMed ID: 20873420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation.
    Mazur D; Schug BS; Evers G; Larsimont V; Fieger-Büschges H; Gimbel W; Keilbach-Bermann A; Blume HH
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):386-92. PubMed ID: 10475141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.
    Hill SW; Varker AS; Karlage K; Myrdal PB
    J Manag Care Pharm; 2009 Apr; 15(3):253-61. PubMed ID: 19326956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations.
    Richard J; Cardot JM; Godbillon J
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):375-80. PubMed ID: 7737240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.
    Vuletić L; Khan MZI; Špoljarić D; Radić M; Cetina-Čižmek B; Filipović-Grčić J
    Pharm Res; 2018 Jun; 35(8):163. PubMed ID: 29934663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulated release metoprolol succinate formulation based on ionic interactions: in vivo proof of concept.
    Ravishankar H; Patil P; Samel A; Petereit HU; Lizio R; Iyer-Chavan J
    J Control Release; 2006 Mar; 111(1-2):65-72. PubMed ID: 16446006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride.
    Likar MD; Mansour HL; Harwood JW
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):543-51. PubMed ID: 15975755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioequivalence evaluation of two rosiglitazone tablet formulations.
    Yusuf A; Al-Gaai E; Hammami MM
    Arzneimittelforschung; 2006; 56(11):740-3. PubMed ID: 17220051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.